Related Experiment Video
Updated: Dec 20, 2025

Tissue Characterization after a New Disaggregation Method for Skin Micro-Grafts Generation
Published on: March 4, 2016
Report of the Skin Research Workgroups from the GRAPPA 2019 Annual Meeting
Lourdes M Perez-Chada1,2,3, Joseph F Merola1,2,3, April W Armstrong1,2,3
1From the Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Icahn School of Medicine at Mt. Sinai, New York, New York; Department of Dermatology, Keck School of Medicine, University of Southern California (USC), Los Angeles, California, USA.
Abstract:
The International Dermatology Outcome Measures (IDEOM) initiative is a nonprofit organization dedicated to enhancing clinical care and research in dermatology by developing evidence-based, patient-centered outcome measures. At the 2019 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the IDEOM psoriasis working group presented an overview of its selected deliverables and discussed its efforts to agree on meaningful, valid, and feasible outcome measures for quality measurement in psoriasis. The psoriatic arthritis (PsA) workgroup focused on the measurement of PsA symptoms in psoriasis clinical trials, and the measurement of nonspecific musculoskeletal symptoms among patients with psoriasis in psoriasis longitudinal clinical trials and cohort studies.

